Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

NCT: NCT06511141 · RECRUITING

NCT IDNCT06511141
StatusRECRUITING
Start Date2024-10-22
Completion2028-12

Brief Summary

To assess the post-market clinical outcomes of the Axonics SNM System for treatment of overactive bladder in male patients.

Frequently Asked Questions

What is Sacral Neuromodulation for Male Overactive Bladder (MOAB)?

Sacral Neuromodulation for Male Overactive Bladder (MOAB) is a clinical trial registered under NCT06511141. Current status: RECRUITING.

What is the status of NCT06511141?

The current status of NCT06511141 (Sacral Neuromodulation for Male Overactive Bladder (MOAB)) is: RECRUITING.

When did Sacral Neuromodulation for Male Overactive Bladder (MOAB) start?

Sacral Neuromodulation for Male Overactive Bladder (MOAB) started on 2024-10-22.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑